Literature DB >> 7786031

Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.

C Beedham1, D J Critchley, D J Rance.   

Abstract

Partially purified aldehyde oxidase (EC 1.2.3.1) has been prepared from human, rabbit, guinea pig, and baboon liver by heat treatment and precipitation with ammonium sulfate. The interaction of 35 substituted quinazolines and phthalazines with human liver enzyme has been studied using a spectrophotometric assay. Fifteen quinazoline and 14 phthalazine derivatives were found to be substrates for human liver aldehyde oxidase with Km values ranging from 5 to 500 microM. The substrate specificity of the quinazolines toward rabbit, guinea pig, and baboon liver aldehyde oxidase has also been investigated; the reaction of substituted phthalazines with mammalian liver enzyme has been reported previously (Beedham et al., 1990, Biochem. Pharmacol. 39, 1213-1221). Oxidation products of 2-substituted (4-substituted) quinazolines with rabbit liver aldehyde oxidase were identified by MS as 4-oxo (2-oxo)-quinazolines, respectively. In all cases, unsubstituted compounds gave the highest oxidation rates and the presence of lipophilic substituents presumably facilitated hydrophobic binding to the enzymes. However, there were marked differences in substrate specificity between human liver aldehyde oxidase and hepatic enzyme from rabbit, guinea pig, and baboon with the size of substrate being the differentiating factor. The molecular sizes of the substrates, estimated using calculated molar refractivities, ranked the size of the binding site of aldehyde oxidase in the order rabbit < guinea pig < baboon < man. Isoelectric points of the different aldehyde oxidase isozymes ranged from pH 5.10 for rabbit to 6.40 for the human liver isozyme. These results indicate that rabbit liver aldehyde oxidase shows marked differences from the human liver enzyme in its handling of quinazoline and phthalazine substrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786031     DOI: 10.1006/abbi.1995.1320

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation.

Authors:  Tapan K Kundu; Murugesan Velayutham; Jay L Zweier
Journal:  Biochemistry       Date:  2012-03-19       Impact factor: 3.162

Review 2.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

3.  A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834.

Authors:  Jasleen K Sodhi; Susan Wong; Donald S Kirkpatrick; Lichuan Liu; S Cyrus Khojasteh; Cornelis E C A Hop; John T Barr; Jeffrey P Jones; Jason S Halladay
Journal:  Drug Metab Dispos       Date:  2015-04-06       Impact factor: 3.922

4.  Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues.

Authors:  Tapan Kumar Kundu; Russ Hille; Murugesan Velayutham; Jay L Zweier
Journal:  Arch Biochem Biophys       Date:  2007-01-23       Impact factor: 4.013

5.  Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes.

Authors:  Aristidis S Veskoukis; Demetrios Kouretas; Georgios I Panoutsopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

Review 6.  Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.

Authors:  Enrico Garattini; Ralf Mendel; Maria João Romão; Richard Wright; Mineko Terao
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

7.  Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.

Authors:  Rachel D Crouch; Ryan D Morrison; Frank W Byers; Craig W Lindsley; Kyle A Emmitte; J Scott Daniels
Journal:  Drug Metab Dispos       Date:  2016-03-02       Impact factor: 3.922

8.  Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.

Authors:  Kanika V Choughule; John T Barr; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2013-08-05       Impact factor: 3.922

9.  Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli.

Authors:  Joshua F Alfaro; Carolyn A Joswig-Jones; Wenyun Ouyang; Joseph Nichols; Gregory J Crouch; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2009-09-09       Impact factor: 3.922

10.  Flavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidase.

Authors:  Chrysoula Spanou; Aristidis S Veskoukis; Thalia Kerasioti; Maria Kontou; Apostolos Angelis; Nektarios Aligiannis; Alexios-Leandros Skaltsounis; Dimitrios Kouretas
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.